secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001437749-24-014372
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Vascular Q1 sales $53.5M (+14%), EPS $0.44 (+62%); raises FY op. margin guidance to 22%
--------------------------------------------------------------------------------

- Q1 net income $9.9M (+64%); gross margin 68.6% (+300 bps) on price increases and manufacturing efficiencies.
- Allografts (+31%), carotid shunts (+27%), and APAC sales (+44%) led growth; organic sales +11%.
- Board declared $0.16/share dividend payable May 30 to holders of record May 16.
- FY 2024 guided sales $212.7-217.3M (+11%), EPS $1.73-1.84 (+33% vs. FY 2023), operating margin 22%.
- Share repurchase program of up to $50M authorized through Feb 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774924014372/0001437749-24-014372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774924014372/lmat20240502_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-014372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer